The Vall d´Hebron Institute of Oncology (VHIO) Currently Seeks PhD Student – Immediate Call for Applications –
To join our recently created Experimental Hematology Group headed by Francesc Bosch, we are currently inviting applications for the position of PhD Student, funded by the (ISC) Institute de Salut Carlos III.
We seek:
An enthusiastic and highly motivated candidate with proven ability to work as part of a team. Experience in this field it would be considered.
Application:
To join our group and contribute to this exciting, highly stimulating research project based within the interactive and thriving environment of the Vall d´Hebron Institute of Oncology (VHIO) – a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, please submit a cover letter describing your research interests and curriculum vitae via email to: selecciorrhh@vhio.net
Review of applications will commence immediately.
VHIO provides:
A dynamic, multidisciplinary research environment, optimal laboratory space and access to our cutting-edge core technologies: Molecular Oncology, Cancer Genomics, Translational Genomics, and Proteomics which are not only responsible for the development of VHIO´s core technologies and platforms but also pursue, implement and develop their own independent research lines and projects. Located in the stunning city that is Barcelona, our exceptional facilities also comprise a state-of-the-art animal facility with a dedicated surface area of 1347 m2 and a capacity of 5471 cages.
Additional Information
Established in 2006, the Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain, is a leading comprehensive cancer center of excellence where its scientists and research physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer.
Undertaking one of Spain´s most dynamic cancer research programs, VHIO is dedicated to delivering on the promise of precision medicine in oncology – turning cancer discovery into more effective, tailored treatments and better practice for the care of our patients.
Marking a new chapter in VHIO´s evolution and affording us with the valuable space through which to grow, our new home since September last year – the CELLEX Building, now brings all our teams under the same roof which is instrumental in further enhancing collaboration and the connection between our various programs.
To discover more about VHIO, its Faculty, research programs and activities visit: www.vhio.net.
